- BioNTech ‘carefully watching’ costs as COVID vaccine sales sink FiercePharma
- BioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript Yahoo Finance
- BioNTech slashes expected R&D spend for 2023 amid cost-cutting FierceBiotech
- View Full Coverage on Google News
Source link